Clinical Trial Update: Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients [NA]

View source ↗

Summary

A clinical trial comparing conventional versus hypofractionated radiation in high-risk prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: High-risk Prostate Cancer | NA | Status: TERMINATED